Coulter Partners announces top global hires for large-cap, mid-cap and public companies (H2-2023)

Function

Focus area

Location

CEO

Novel enzymes (publicly listed)

Nordics

Chief Commercial Officer

Specialty pharma (mid-cap)

Europe

Chief Medical Officer

Biopharma (publicly listed)

US

Chief Financial Officer

Biotech (publicly listed)

US

Chief of Staff

Medtech (mid-cap)

Europe

Board Director

Biopharma (publicly listed)

Europe

Board Director

Biotech (publicly listed)

US

Function

Focus area

Location

Regional VP N. Europe & Australia

Biopharma (large-cap)

Europe/ APAC/ US

SVP Finance

Biopharma (mid-cap)

US

VP People, Americas

Prosthetics (mid-cap)

US/ Nordics

VP Marketing

Biopharma (publicly listed)

US

VP Product

Ophthalmic technology (mid-cap)

Europe

Global Head of Marketing

Specialty ingredients (large-cap)

Nordics

Head of Business Development

Biopharma (publicly listed)

Europe

Global Key Account Manager

Specialty chemicals (large-cap)

Europe

Senior Communications Leader

Global pharma (large-cap)

Europe

SE Asia, Japan, China Area Director

Animal health (large-cap)

APAC/ Europe

Commercial Director

Digital health (publicly listed)

Europe

Function

Focus area

Location

Global R&D Director ORS Engineering

Surgical products (mid-cap)

Nordics

Head of Neuroscience

Pharma (mid-cap)

Europe

Head of Rheumatology

Generics (large-cap)

APAC/ Europe

VP Regulatory Affairs

Pharma (mid-cap)

Europe/US

Global Compliance Director

Specialty pharma (mid-cap)

Europe

Senior Medical Director

Women’s health (publicly listed)

US

Medical Director, Canada

Biotech (large-cap)

US/Canada

Regulatory Strategy Director, Specialist Nutrition

Food products (large-cap)

Europe

Clinical Development Director

Specialty pharma (large-cap)

Europe